Overview

Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Sugammadex in rapidly reversing deep neuromuscular blockaded (induced by rocuronium)
Phase:
Phase 4
Details
Lead Sponsor:
University of South Florida
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Glycopyrrolate
Neostigmine